Olimpio Franceschi, Puerto Rico
When Olimpio first heard about STEMTech, it was from his doctor and friend, Enrique Martinez, whose help Olimpio had sought for a very uncomfortable problem with his jaw. “I couldn't open my mouth for three days,” he explains. Having just returned from STEMTech's Launch Celebration in California, Dr. Martinez knew just what
to suggest - StemEnhance™. With the first capsules, Olimpio felt “something was going on.” By the next afternoon, his discomfort was gone and he could enjoy a meal again. Soon Olimpio noticed that other physical challenges that had kept him from enjoying life to the fullest were diminishing. His wife Annie began taking the
product too, and soon she was once again able to climb stairs, which had been impossible to her for years. “I saw these results, and I knew I had to take the StemEnhance™ message to others,” he explains.
He became an Embajadores de la Salud (Health Ambassador) and began traveling all over the island of Puerto Rico sharing StemEnhance™. “I learned that not only could I deliver health to the people of my country, but also I could make a good income for my family,” he says. Olimpio's climb up the STEMTech ladder has been steady
and very rapid. Each month he moved up a level, making Double Diamond after only seven months in business.
For Olimpio, the STEMTech business is simple. “I talk to people about the benefits of good health, and then I suggest they take StemEnhance™ and let their bodies talk to them. Once they see what StemEnhance™ does for them, they want to tell everyone about it!”
Deborah Sanders, Florida
“For many years, I was never fully asleep at night or fully awake during the day,”Deborah says. Her troublesome physical challenges curtailed any hope she may have had to lead a “normal” life. She became depressed and stayed away from people. “I suffered a lot of abuse from people who didn't understand my situation. They just assumed I was on prescription drugs or something,” she says. Last December, Deborah began taking StemEnhance™. “Within a few hours, I began to feel strange. I was suddenly aware of my surroundings, crystal clear,” she says. “It was almost frightening!” Deborah says that over the next few days it was as though her mind
had “awakened.”That night she went to bed and got up the next morning to a surprise. “I was awake, completely awake, and I stayed awake and alert all day!” Deborah couldn't believe it. “I had been partially asleep for 22 years I felt like I had gotten my life back,” she says. Deborah began calling people to share the good news. “Many people had never seen me really awake and alert,” she says ruefully. “But when they came over to the house and saw the change in me, they wanted to know how I did it.
I started handing out the StemEnhance™ Story DVDs and people started signing up.” Deborah says it has all been like a dream -- in a good way. “I feel like I've gone from rags to riches. I am awake and I am happy. Thank you, StemEnhance™!”
Laurie Powers, Michigan
A professional photographer, Laurie Powers was just coming out of her busy season when she began to notice a sudden change in her vision and a prickly sensation in her arms. “Something's not right,” she thought. Medical tests were inconclusive with the doctors saying she “might” be facing a long-term physical challenge. When they suggested a regimen of shots, Laurie's stress level went through the roof. She opted out of further treatment and went home to think. “I called my friends and asked for their prayers,” Laurie says. “My energy was gone. I was scared, and I didn't know what was happening to me.” Then one of her mother's friends suggested she should
try a new product called StemEnhance™.
Laurie checked the STEMTech web site and was so intrigued by the science behind this breakthrough product that she ordered a bottle. “Within two days of taking my first capsules my energy was up and my stress level was way down,” Laurie says. Since then, my troubling symptoms have been going away and I am feeling really good again. I thank StemEnhance™ for helping my body to maintain optimal health."
Vickie Shackelford, Texas
Vickie Shackelford led a pretty normal life until a slip on water at a Pizza Hut in 1992 changed things forever. “In an instant, I became a paraplegic, “she says.” Everything from my hip joint down is dead and surgery could not fix it.” To make matters worse, she was going through a divorce at the same time. With every reason to feel sorry for myself, “I decided to go on,” she says.” Once I realized that I am the same person that I was when I StemEnhance™ could walk, I was okay. Then I began pursuing wellness.” Over the next few years, Vickie kept an eye out for
new medical breakthroughs and maintained an all natural approach to health.
Then in April 2006, she was going down a ramp in her wheelchair holding a baby when the chair tipped over to protect the baby, Vickie landed hard on her shoulders, and ended up needing surgery on both of them. “I wore two slings so I couldn't do anything for myself. It was horrible!” A friend suggested that StemEnhance™ could help her body help itself.
Not expecting too much, Vickie took four StemEnhance™ capsules the first day, four the second, then noticed she had no more post-op discomfort. When the doctors told her it could be more than two years before she would have the use of her arms again, she says, “I decided to take six StemEnhance™ a day work really hard on my therapy and see what happens.” Six months later, she could raise both arms and do her own hair. “My doctors were shocked,” she says. She gets around nowadays in an electric wheelchair and drives a van adapted for her. It's a good thing, too. Vickie's a busy lady full of energy, who runs several local organizations.
Gaelen Straughn, Florida
Gaelen Straughn was tired, anxious and sleep-deprived. She says, “Even the idea of preparing meals for my three kids could put me over the edge.” Not one to use doctors, Gaelen tried to improve her life with a change in diet to one heavy on raw foods. And she started taking live AFA. “The raw food diet worked for awhile,” she says, “but then I hit a plateau.” A friend had heard Christian Drapeau speak about StemEnhance™ and suggested Gaelen should try it. “What this product can do is amazing!” her friend told her.
Within the first few days, Gaelen had to agree with her friend. “My anxiety subsided, my sleep patterns improved, and I was feeling good for the first time in years.” Gaelen went FastStart, and began telling others about her experience with StemEnhance™. In the months since, Gaelen has continued to enjoy life. “And recently I've noticed that about 40 percent of my full head of gray hair has been coming in brown again. That is something. StemEnhance™ is really an amazing product!”
Dr. Baxter D. Montgomery, M.D. - "We have had excellent results with Aphanizomenon flos-aquae (AFA) in our disease reversal program, specifically with cardiac disease, hyperlipidemia, and diabetes. Within a few days of starting to drink AFA, my staff and I noticed a leap in our stamina during our workouts, an incredible boost in our mental clarity and ability to stay focused, and a decrease in our appetite. Our patients have commented that they are losing cravings for "the bad foods" as they continue to drink AFA. We are amazed and overjoyed at the tremendous results we see with regular use of this live super food." – Dr. Baxter D. Montgomery, MD with the Houston Cardiac Association, HCA Wellness and Disease Reversal
Friday, July 31, 2009
Thursday, July 30, 2009
WHAT IS STEM CELL ENHANCERS?
Stem Enhance a natural botanical extract, is a breakthrough PATENTED product that supports the release of your own adult stem cells from your bone marrow into your bloodstream. The resulting increase in the number of circulating adult stem cells - up to 30% - can greatly assist your body's natural ability to maintain youthfulness, vitality and optimal health!
When StemEnhance is used as a daily supplement over time, the circulation of millions of additional stem cells in the bloodstream could be one of the safest and most efficient methods for maintaining optimal health that science has yet discovered.
Stem Cell Enhancers support the natural release of Adult Stem Cells from our own bone marrow. The only stem cell enhancer available is a natural botanical extract. It is a blend of 2 compounds extracted from the cyanophyta Aphanizomenon Flos – aquae (AFA)…blue green algae in Klamath Lake. These compounds are extracted using a proprietary process that utilizes no chemicals, or harsh agents and is highly concentrated in the product.
One extract contains an L-selectin ligand, which supports the release of stem cells (CD34+cells) from the bone marrow. The other extract a polysaccharide-rich fraction named MigratoseTM, supports the migration of stem cells to tissue in the body needing repair.
StemEnhance® is a blend of two compounds extracted from the cyanophyta Aphanizomenon flos-aquae (AFA). These compounds are extracted using a proprietary process that utilizes no chemicals or harsh agents.
One extract, which contains an L-selectin ligand, supports the release of stem cells (CD34+ cells) from the bone marrow. The other extract, a polysaccharide-rich fraction named Migratose™, may support the migration of stem cells out of the blood into tissues.
Quick Facts on the new StemEnhance® by StemTech:
* Supports the natural & safe release of adult stem cells from the bone marrow
* Supports the migration of stem cells to tissue in your body needing repair
* Proven to increase the number of circulating stem cells by up to 30% (about 3 to 4
million stem cells),
* No ethical controversy; safe to use
* Additional benefits include anti-inflammatory and immune system support, mental
clarity and mood elevation
* Patented natural aquabotanical extract (Patent#: 6,814,961 B1)
When StemEnhance is used as a daily supplement over time, the circulation of millions of additional stem cells in the bloodstream could be one of the safest and most efficient methods for maintaining optimal health that science has yet discovered.
Stem Cell Enhancers support the natural release of Adult Stem Cells from our own bone marrow. The only stem cell enhancer available is a natural botanical extract. It is a blend of 2 compounds extracted from the cyanophyta Aphanizomenon Flos – aquae (AFA)…blue green algae in Klamath Lake. These compounds are extracted using a proprietary process that utilizes no chemicals, or harsh agents and is highly concentrated in the product.
One extract contains an L-selectin ligand, which supports the release of stem cells (CD34+cells) from the bone marrow. The other extract a polysaccharide-rich fraction named MigratoseTM, supports the migration of stem cells to tissue in the body needing repair.
StemEnhance® is a blend of two compounds extracted from the cyanophyta Aphanizomenon flos-aquae (AFA). These compounds are extracted using a proprietary process that utilizes no chemicals or harsh agents.
One extract, which contains an L-selectin ligand, supports the release of stem cells (CD34+ cells) from the bone marrow. The other extract, a polysaccharide-rich fraction named Migratose™, may support the migration of stem cells out of the blood into tissues.
Quick Facts on the new StemEnhance® by StemTech:
* Supports the natural & safe release of adult stem cells from the bone marrow
* Supports the migration of stem cells to tissue in your body needing repair
* Proven to increase the number of circulating stem cells by up to 30% (about 3 to 4
million stem cells),
* No ethical controversy; safe to use
* Additional benefits include anti-inflammatory and immune system support, mental
clarity and mood elevation
* Patented natural aquabotanical extract (Patent#: 6,814,961 B1)
History of Stem Cell Research
The history of stem cell research had a benign, embryonic beginning in the mid 1800's with the discovery that some cells could generate other cells. Now stem cell research is embroiled in a controversy over the use of human embryonic stem cells for research. In the early 1900's the first real stem cells were discovered when it was found that some cells generate blood cells.
The history of stem cell research includes work with both animal and human stem cells. Stem cells can be classified into three broad categories, based on their ability to differentiate. Totipotent stem cells are found only in early embryos. Each cell can form a complete organism (e.g., identical twins). Pluripotent stem cells exist in the undifferentiated inner cell mass of the blastocyst and can form any of the over 200 different cell types found in the body. Multipotent stem cells are derived from fetal tissue, cord blood, and adult stem cells. Although their ability to differentiate is more limited than pluripotent stem cells, they already have a track record of success in cell-based therapies.
A prominent application of stem cell research has been bone marrow transplants using adult stem cells. In the early 1900's physicians administered bone marrow by mouth to patients with anemia and leukemia. Although such therapy was unsuccessful, laboratory experiments eventually demonstrated that mice with defective marrow could be restored to health with infusions into the blood stream of marrow taken from other mice. This caused physicians to speculate whether it was feasible to transplant bone marrow from one human to another (allogeneic transplant). Among early attempts to do this were several transplants carried out in France following a radiation accident in the late 1950's. Performing marrow transplants in humans was not attempted on a larger scale until a French medical researcher made a critical medical discovery about the human immune system. In 1958 Jean Dausset identified the first of many human histocompatibility antigens. These proteins, found on the surface of most cells in the body, are called human leukocyte antigens, or HLA antigens. These HLA antigens give the body's immune system the ability to determine what belongs in the body and what does not belong. Whenever the body does not recognize the series of antigens on the cell walls, it creates antibodies and other substances to destroy the cell.
A bone marrow transplant between identical twins guarantees complete HLA compatibility between donor and recipient. These were the first kinds of transplants in humans. It was not until the 1960's that physicians knew enough about HLA compatibility to perform transplants between siblings who were not identical twins. In 1973 a team of physicians performed the first unrelated bone marrow transplant. It required 7 transplants to be successful. In 1984 Congress passed the National Organ Transplant Act, which among other things, included language to evaluate unrelated marrow transplantation and the feasibility of establishing a national donor registry. This led ultimately to National Marrow Donor Program (NDWP) a separate non-profit organization that took over the administration of the database needed for donors in 1990. The 1990's saw rapid expansion and success of the bone marrow program with more than 16,000 transplants to date for the treatment of immunodeficiencies and leukemia. Adult stem cells also have shown great promise in other areas. These cells have shown the potential to form many different kinds of cell types and tissues, including functional hepatocyte-like (liver) cells. Such cells might be useful in repairing organs ravaged by diseases.
In 1998, James Thompson (University of Wisconsin - Madison) isolated cells from the inner cell mass of early embryos, and developed the first embryonic stem cell lines. In the same year, John Gearhart (Johns Hopkins University) derived germ cells from cells in fetal gonadal tissue (primordial germ cells). Pluripotent stem cell "lines" were developed from both sources. The blastocysts used for human stem cell research typically come from in vitro fertilization (IVF) procedures. The ethical concerns over this type of embryonic stem cell research has been expressed in the following US legal regulations:
In 1973 a moratorium was placed on government funding for human embryo research. In 1988 a NIH panel voted 19 to 2 in favor of government funding. In 1990, Congress voted to override the moratorium on government funding of embryonic stem cell research, which was vetoed by President George Bush. President Clinton lifted the ban, but changed his mind the following year after public outcry. Congress banned federal funding in 1995. In 1998 DHHS Secretary Sullivan extended the moratorium. In 2000, President Bill Clinton allowed funding of research on cells derived from aborted human fetuses, but not from embryonic cells. On August 9, 2001, President George W. Bush announced his decision to allow Federal funding of research only on existing human embryonic stem cell lines created prior to his announcement. His concern was to not foster the continued destruction of living human embryos. In 2004, both houses of Congress have asked President George W. Bush to review his policy on embryonic stem cell research. President George W. Bush released a statement reiterating his moral qualms about creating human embryos to destroy them, and refused to reverse the federal policy banning government funding of ESC research (other than for ESC lines established before the funding ban).
In the November 2004 election, California had a Stem Cell Research Funding authorization initiative on the ballot that won by a 60% to 40% margin. It established the "California Institute for Regenerative Medicine" to regulate stem cell research and research facilities. It authorizes issuance of general obligation bonds to finance institute activities up to $3 billion dollars subject to an annual limit of $350 million.
A LITTLE over two decades ago, a new herbal supplement named Aphanizomenon flos-aquae (AFA), an aquatic botanical, made its appearance on the marketplace. Rapidlly, AFA became popular for the wide variety of health benefits reported by consumers. Over the years we identified the presence in AFA of various bioactive compounds such as phycocyanin, a strong natural anti-inflammatory compound, a polysaccharide supporting immune function, and phenylethylamine (PEA), a molecule knows as "the molecule of love," which increases mental clarity and provides a sense of well-being. Nevertheless, in spite of the identification of these various components, many health benefits reported by consumers remained unexplained.
Soon after, studies revealed that adult stem cells (ASC) also had the ability of becoming virtually any kind of cells in the body. When this discovery was made, we hypothesized that ASC constituted the natural renewal sytem of the body, and we published this hypothesis in the journal, Medical Hypotheses (October 2002). Our idea at the time was this: if ASC indeed constituted the natural renewal system of the body, with ASC being able to become any cell type of the body, then supporting this process could lead to a wide variety of health benefits. Given the broad spectrum of benefits reported by AFA consumers, we simply hypothesized that AFA was supporting aspects of stem cell physiology.
The history of stem cell research includes work with both animal and human stem cells. Stem cells can be classified into three broad categories, based on their ability to differentiate. Totipotent stem cells are found only in early embryos. Each cell can form a complete organism (e.g., identical twins). Pluripotent stem cells exist in the undifferentiated inner cell mass of the blastocyst and can form any of the over 200 different cell types found in the body. Multipotent stem cells are derived from fetal tissue, cord blood, and adult stem cells. Although their ability to differentiate is more limited than pluripotent stem cells, they already have a track record of success in cell-based therapies.
A prominent application of stem cell research has been bone marrow transplants using adult stem cells. In the early 1900's physicians administered bone marrow by mouth to patients with anemia and leukemia. Although such therapy was unsuccessful, laboratory experiments eventually demonstrated that mice with defective marrow could be restored to health with infusions into the blood stream of marrow taken from other mice. This caused physicians to speculate whether it was feasible to transplant bone marrow from one human to another (allogeneic transplant). Among early attempts to do this were several transplants carried out in France following a radiation accident in the late 1950's. Performing marrow transplants in humans was not attempted on a larger scale until a French medical researcher made a critical medical discovery about the human immune system. In 1958 Jean Dausset identified the first of many human histocompatibility antigens. These proteins, found on the surface of most cells in the body, are called human leukocyte antigens, or HLA antigens. These HLA antigens give the body's immune system the ability to determine what belongs in the body and what does not belong. Whenever the body does not recognize the series of antigens on the cell walls, it creates antibodies and other substances to destroy the cell.
A bone marrow transplant between identical twins guarantees complete HLA compatibility between donor and recipient. These were the first kinds of transplants in humans. It was not until the 1960's that physicians knew enough about HLA compatibility to perform transplants between siblings who were not identical twins. In 1973 a team of physicians performed the first unrelated bone marrow transplant. It required 7 transplants to be successful. In 1984 Congress passed the National Organ Transplant Act, which among other things, included language to evaluate unrelated marrow transplantation and the feasibility of establishing a national donor registry. This led ultimately to National Marrow Donor Program (NDWP) a separate non-profit organization that took over the administration of the database needed for donors in 1990. The 1990's saw rapid expansion and success of the bone marrow program with more than 16,000 transplants to date for the treatment of immunodeficiencies and leukemia. Adult stem cells also have shown great promise in other areas. These cells have shown the potential to form many different kinds of cell types and tissues, including functional hepatocyte-like (liver) cells. Such cells might be useful in repairing organs ravaged by diseases.
In 1998, James Thompson (University of Wisconsin - Madison) isolated cells from the inner cell mass of early embryos, and developed the first embryonic stem cell lines. In the same year, John Gearhart (Johns Hopkins University) derived germ cells from cells in fetal gonadal tissue (primordial germ cells). Pluripotent stem cell "lines" were developed from both sources. The blastocysts used for human stem cell research typically come from in vitro fertilization (IVF) procedures. The ethical concerns over this type of embryonic stem cell research has been expressed in the following US legal regulations:
In 1973 a moratorium was placed on government funding for human embryo research. In 1988 a NIH panel voted 19 to 2 in favor of government funding. In 1990, Congress voted to override the moratorium on government funding of embryonic stem cell research, which was vetoed by President George Bush. President Clinton lifted the ban, but changed his mind the following year after public outcry. Congress banned federal funding in 1995. In 1998 DHHS Secretary Sullivan extended the moratorium. In 2000, President Bill Clinton allowed funding of research on cells derived from aborted human fetuses, but not from embryonic cells. On August 9, 2001, President George W. Bush announced his decision to allow Federal funding of research only on existing human embryonic stem cell lines created prior to his announcement. His concern was to not foster the continued destruction of living human embryos. In 2004, both houses of Congress have asked President George W. Bush to review his policy on embryonic stem cell research. President George W. Bush released a statement reiterating his moral qualms about creating human embryos to destroy them, and refused to reverse the federal policy banning government funding of ESC research (other than for ESC lines established before the funding ban).
In the November 2004 election, California had a Stem Cell Research Funding authorization initiative on the ballot that won by a 60% to 40% margin. It established the "California Institute for Regenerative Medicine" to regulate stem cell research and research facilities. It authorizes issuance of general obligation bonds to finance institute activities up to $3 billion dollars subject to an annual limit of $350 million.
A LITTLE over two decades ago, a new herbal supplement named Aphanizomenon flos-aquae (AFA), an aquatic botanical, made its appearance on the marketplace. Rapidlly, AFA became popular for the wide variety of health benefits reported by consumers. Over the years we identified the presence in AFA of various bioactive compounds such as phycocyanin, a strong natural anti-inflammatory compound, a polysaccharide supporting immune function, and phenylethylamine (PEA), a molecule knows as "the molecule of love," which increases mental clarity and provides a sense of well-being. Nevertheless, in spite of the identification of these various components, many health benefits reported by consumers remained unexplained.
Soon after, studies revealed that adult stem cells (ASC) also had the ability of becoming virtually any kind of cells in the body. When this discovery was made, we hypothesized that ASC constituted the natural renewal sytem of the body, and we published this hypothesis in the journal, Medical Hypotheses (October 2002). Our idea at the time was this: if ASC indeed constituted the natural renewal system of the body, with ASC being able to become any cell type of the body, then supporting this process could lead to a wide variety of health benefits. Given the broad spectrum of benefits reported by AFA consumers, we simply hypothesized that AFA was supporting aspects of stem cell physiology.
Subscribe to:
Posts (Atom)
